Health News Archive - February 18, 2009
DUBLIN, Ireland, February 18 /PRNewswire/ -- Opsona Therapeutics, a biotechnology company focused on novel therapeutic and preventative approaches to autoimmune and inflammatory diseases, today announced the completion of an EUR18M ($23M) Series B financing round which will enable it to expand both at an operational and clinical level.
CANBERRA, Australia, Feb. 18 /PRNewswire/ -- Growth is expected in Australian pharmaceuticals and life sciences market. In 2007, pharmaceuticals spending on IT accounted for 80 percent or $258.6 million and will continue to drive the growth of this market.
LYON, France, February 18 /PRNewswire-FirstCall/ -- - Global Clinical Study Program Across Dengue Endemic Regions in Latin America and Asia Sanofi Pasteur, the vaccines division of sanofi-aventis Group (EURONEXT : SAN and NYSE : SNY), announced today that its investigational tetravalent dengue vaccine is entering into a pediatric clinical study in Thailand to assess the efficacy of the vaccine in protecting children against dengue, the most widespread tropical disease after malaria.
OAKLAND, Calif., Feb.
IRVINE, Calif., Feb. 18 /PRNewswire/ -- FiSpace.net announces the availability of an exclusive commentary for investors of holding companies including DoMark International, Inc. (OTC Bulletin Board: DOMK), General Electric Co. (NYSE: GE), Berkshire Hathaway Inc.
Conference call to be hosted today at 11:00 a.m. ET BRANFORD, Conn., Feb. 18 /PRNewswire-FirstCall/ -- CuraGen Corporation (Nasdaq: CRGN) announced today that it is undertaking a review of a broad range of strategic alternatives to enhance shareholder value. Robert E.
CINCINNATI, Feb. 18 /PRNewswire-FirstCall/ -- LCA-Vision Inc. (Nasdaq: LCAV) today announced that the Company's Board of Directors has elected Edgar F.
WELLINGTON, Fla., Feb. 18 /PRNewswire-FirstCall/ -- The Quantum Group, Inc. (NYSE Amex: QGP) (www.QuantumMD.com) President & CEO Noel J. Guillama, commented on the President signing the American Recovery and Reinvestment Act of 2009 into law yesterday.
WALL, N.J., Feb. 18 /PRNewswire-FirstCall/ -- BIO-key International, Inc. (OTC Bulletin Board: BKYI) today announced plans to release fourth quarter 2008 financial results on Tuesday, February 24, 2009 before the market opens.